Beta
Losing weight could now be easier than ever. Matthew Schneier discusses the rise of Ozempic, a diabetes drug moonlighting as an off-label appetite suppressant.
MIT Technology Review
Apr 8, 2023 - 34 min
WIRED
Feb 5, 2023 - 12 min
The Wall Street Journal
Jan 8, 2023 - 8 min
Financial Times
Mar 11, 2023 - 30 min
1843
Feb 10, 2023 - 39 min
Salon
Apr 24, 2018 - 17 min